Provided by Tiger Trade Technology Pte. Ltd.

Tonix Pharmaceuticals

9.74
+0.09000.93%
Post-market: 9.930.1900+1.95%19:30 EDT
Volume:318.03K
Turnover:3.10M
Market Cap:167.05M
PE:-0.78
High:9.92
Open:9.62
Low:9.57
Close:9.65
52wk High:25.50
52wk Low:9.40
Shares:17.15M
Float Shares:14.99M
Volume Ratio:0.60
T/O Rate:2.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.4882
EPS(LYR):-14.5713
ROE:-81.82%
ROA:-46.84%
PB:0.75
PE(LYR):-0.67

Loading ...

Tonix Pharmaceuticals Q2 Net Income USD -40.552 Million

THOMSON REUTERS
·
Aug 10

Tonix Pharmaceuticals Holding Corp. Expected to Post a Loss of $2.70 a Share - Earnings Preview

Reuters
·
Aug 08

Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Aug 05

Tonix Publishes Investor Deck Highlighting Tonmya Fibromyalgia Launch and Pipeline Updates

Reuters
·
Aug 04

Tonix Pharmaceuticals receives Type C meeting minutes from FDA for TNX-4800

TIPRANKS
·
Aug 03

Tonix Plans Adaptive Phase 2 Trial of TNX-4800 Antibody to Prevent Lyme Disease, Targets Q1 2027 Start

Reuters
·
Aug 03

Tonix Pharmaceuticals - Plans to Start Phase 2 Tnx-4800 Study in Q1 2027

THOMSON REUTERS
·
Aug 03

Tonix Pharmaceuticals Announces Positive Minutes from Type C FDA Meeting to Discuss Adaptive Phase 2 Field Study of Tnx-4800, a Human, Anti-Ospa Monoclonal Antibody, to Prevent Lyme Disease in the U.S.

THOMSON REUTERS
·
Aug 03

Tonix Pharmaceuticals - Majority of Enrollment Expected in 2028 Season, May Extend into 2029

THOMSON REUTERS
·
Aug 03

Tonix Pharmaceuticals Posts Investor Deck Focused on Tonmya Fibromyalgia Launch and Pipeline Updates

Reuters
·
Jul 28

Tonix Pharma to Report Q2 Results, Host Conference Call and Webcast

Reuters
·
Jul 27

Tonix Pharma CMO Gregory Sullivan to Retire Aug. 20

Reuters
·
Jul 22

Tonix Pharmaceuticals Publishes Investor Deck Highlighting Tonmya Fibromyalgia Launch Strategy

Reuters
·
Jul 20

Tonix Pharmaceuticals Investor Deck Spotlights Tonmya Fibromyalgia Launch and Late-stage Pipeline Plans

Reuters
·
Jul 17

Tonix Publishes Journal of Virology Study Showing 2022 Mpox Clade Iib up to 100,000-fold Less Virulent than 2003 Clade Iia

Reuters
·
Jul 15

Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models

GlobeNewswire
·
Jul 15

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 13

Tonix Rises on Medicare Coverage Expansion for Chronic Pain Treatment

Reuters
·
Jul 13

Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for Tonmya®

THOMSON REUTERS
·
Jul 13

Tonix Pharmaceuticals - Announces Medicare Agreement for Tonmya Adding 9 Mln Lives Effective Jan 1, 2027

THOMSON REUTERS
·
Jul 13